Īrija - angļu - HPRA (Health Products Regulatory Authority)

g & a licensing limited - clarithromycin - tablets - 250 milligram

Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbott laboratories, united kingdom - clarithromycin - coated tablet - 500 mg

Dienvidāfrikas Republika - angļu - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - see ingredients - each tablet contains clarithromycin 500,0 mg

Saūda Arābija - angļu - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbott laboratories, united kingdom - clarithromycin - coated tablet - 500 mg

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

gilead sciences (nz) - efavirenz 600mg;  ;  ;  ; emtricitabine 200mg;  ;  ;  ; tenofovir disoproxil fumarate 300mg;  ;  ;   - film coated tablet - active: efavirenz 600mg       emtricitabine 200mg       tenofovir disoproxil fumarate 300mg       excipient: croscarmellose sodium hyprolose magnesium stearate microcrystalline cellulose opadry pink 85f94172 purified water sodium laurilsulfate - atripla is indicated for the treatment of hiv infected adults over the age of 18 years, alone or in combination with other antiretroviral agents.

Armēnija - angļu - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

aesica queenborough limited - clarithromycin - tablets modified-release film-coated - 500mg

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbott laboratories (m) sdn. bhd. - clarithromycin -

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

viatris limited - clarithromycin 25 mg/ml;  ;   - granules for oral suspension - 125 mg/5ml - active: clarithromycin 25 mg/ml     excipient: carbomer castor oil citric acid monohydrate fruit mix flavour wl-18758 204264 hydrated silica hypromellose phthalate maltodextrin potassium sorbate povidone sucrose titanium dioxide xanthan gum - klacid suspension is indicated for treatment of infections caused by susceptible organisms. such infections include: ? upper respiratory infections (e.g. streptococcal pharyngitis). ? lower respiratory infections (e.g. bronchitis, pneumonia). ? acute otitis media. ? skin and skin structure infections (e.g. impetigo, folliculitis, cellulitis, abscesses). ? disseminated or localized mycobacterial infections due to mycobacterium avium or mycobacterium intracellulare. localised infections due to mycobacterium chelonae, mycobacterium fortuitum or mycobacterium kansasii.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

b & s healthcare - clarithromycin - tablets - 250 milligram

Īrija - angļu - HPRA (Health Products Regulatory Authority)

g & a licensing limited - clarithromycin - tablets - 250 milligram